Healthequity (NASDAQ:HQY) will issue its quarterly earnings data after the market closes on Monday, March 18th. Analysts expect the company to announce earnings of $0.15 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Shares of NASDAQ HQY opened at $82.16 on Friday. Healthequity has a 12 month low of $50.29 and a 12 month high of $101.58. The firm has a market cap of $5.10 billion, a PE ratio of 152.15, a P/E/G ratio of 2.68 and a beta of 1.72.

In related news, VP Darcy G. Mott sold 4,000 shares of the stock in a transaction dated Tuesday, January 22nd. The stock was sold at an average price of $60.81, for a total value of $243,240.00. Following the completion of the sale, the vice president now directly owns 79,200 shares of the company’s stock, valued at approximately $4,816,152. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Delano Ladd sold 6,875 shares of the stock in a transaction dated Wednesday, February 20th. The stock was sold at an average price of $78.00, for a total value of $536,250.00. Following the completion of the sale, the executive vice president now directly owns 14,340 shares of the company’s stock, valued at $1,118,520. The disclosure for this sale can be found here. Over the last three months, insiders sold 18,875 shares of company stock valued at $1,332,090. Company insiders own 4.00% of the company’s stock.

HQY has been the subject of several analyst reports. SunTrust Banks raised Healthequity from a “hold” rating to a “buy” rating and set a $81.00 target price for the company in a report on Thursday, February 7th. BidaskClub downgraded Healthequity from a “hold” rating to a “sell” rating in a report on Monday, January 7th. ValuEngine raised Healthequity from a “hold” rating to a “buy” rating in a report on Monday, February 4th. Cantor Fitzgerald raised Healthequity from a “neutral” rating to an “overweight” rating and set a $82.00 price objective for the company in a research note on Monday, December 17th. Finally, Citigroup set a $102.00 price objective on Healthequity and gave the stock a “buy” rating in a research note on Tuesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $87.85.

ILLEGAL ACTIVITY NOTICE: This report was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2019/03/16/healthequity-hqy-set-to-announce-quarterly-earnings-on-monday.html.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: How much money do you need to begin day trading?

Earnings History for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.